Literature DB >> 6370155

The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.

N Wolmark, B Fisher, H S Wieand, R S Henry, H Lerner, S Legault-Poisson, P J Deckers, N Dimitrov, P H Gordon, P Jochimsen.   

Abstract

This analysis explores the prognostic significance of preoperative carcinoembryonic antigen (CEA) levels in patients with colorectal cancer. The data were derived from 945 patients entered into two randomized prospective clinical trials of the National Surgical Adjuvant Breast and Bowel Project. A strong correlation was evident between preoperative CEA level and Dukes class. The mean CEA progressively increased with each Dukes category and the mean value for each of the four classes was significantly different. This relationship was prevalent whether the data were analyzed for all colorectal lesions regardless of location or specifically for right-sided colon tumors. The prognostic function of preoperative CEA level was independent of the number of positive histologic nodes. Preoperative CEA level correlated with the degree of lumen encirclement by tumor. Tumors that did not encircle more than one half the lumen were associated with significantly lower preoperative CEA levels than those that did. The presence or absence of lumen obstruction was unrelated to the preoperative CEA level. The relative risk of developing a treatment failure was associated with preoperative CEA, in both Dukes B and C patients, demonstrating that the prognostic significance of preoperative CEA was independent of Dukes class.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370155      PMCID: PMC1353353          DOI: 10.1097/00000658-198404000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  Carcinoembryonic antigen in families.

Authors:  H L Lynch; H Guirgis
Journal:  JAMA       Date:  1973-05-14       Impact factor: 56.272

2.  Editorial: Immunochemical studies of carcinoembryonic antigens: methodologic considerations and some clinical implications.

Authors:  H Z Zupchik; N Zamcheck; C A Saravis
Journal:  J Natl Cancer Inst       Date:  1973-12       Impact factor: 13.506

3.  Demonstration of an antigen common to several varieties of neoplasia.

Authors:  P Lo Gerfo; J Krupey; H J Hansen
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

4.  Carcinoembryonic antigen in patients with different cancers.

Authors:  G Reynoso; T M Chu; D Holyoke; E Cohen; T Nemoto; J J Wang; J Chuang; P Guinan; G P Murphy
Journal:  JAMA       Date:  1972-04-17       Impact factor: 56.272

5.  Cancer of the colon: the influence of the no-touch isolation technic on survival rates.

Authors:  R B Turnbull; K Kyle; F R Watson; J Spratt
Journal:  Ann Surg       Date:  1967-09       Impact factor: 12.969

6.  Carcinoembryonic antigen in serum in diseases of the liver and pancreas.

Authors:  S K Khoo; I R Mackay
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

7.  Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer.

Authors:  H J Hansen; J J Snyder; E Miller; J P Vandevoorde; O N Miller; L R Hines; J J Burns
Journal:  Hum Pathol       Date:  1974-03       Impact factor: 3.466

8.  The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

Authors:  D M Thomson; J Krupey; S O Freedman; P Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract.

Authors:  D Holyoke; G Reynoso; T M Chu
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  43 in total

1.  Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine.

Authors:  Everardo D Saad; Marcel C Machado; Dalia Wajsbrot; Roberto Abramoff; Paulo M Hoff; Jacques Tabacof; Artur Katz; Sergio D Simon; René C Gansl
Journal:  Int J Gastrointest Cancer       Date:  2002

Review 2.  Progress in the development of prognostic and predictive markers for gastrointestinal malignancies.

Authors:  Crystal S Denlinger; Steven J Cohen
Journal:  Curr Treat Options Oncol       Date:  2007-10

3.  [Clinical utility of serous tumoural markers].

Authors:  A Martín Suárez; L Alonso Díaz; I Ordiz Alvarez; J Vázquez; F Vizoso Piñeiro
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

4.  Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Yusuke Nakagawa; Shin Fujita; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2017-02-09       Impact factor: 2.571

5.  Colon carcinoma treated with oxaliplatin and capecitabine in a 12-year-old child.

Authors:  Dong-Lai Hu; Xiao-Dong Guo; Zhi-Nan Sun; Yan-Min Zhao
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

6.  Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period.

Authors:  Roberto Biffi; Edoardo Botteri; Emilio Bertani; Maria Giulia Zampino; Sabina Cenciarelli; Fabrizio Luca; Simonetta Pozzi; Maria Laura Cossu; Antonio Chiappa; Nicole Rotmensz; Barbara Bazolli; Elena Magni; Angelica Sonzogni; Bruno Andreoni
Journal:  Int J Colorectal Dis       Date:  2012-08-19       Impact factor: 2.571

7.  Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.

Authors:  Mi Joo Chung; Taek Keun Nam; Jae Uk Jeong; Sung Hwan Kim; Kyubo Kim; Hong Seok Jang; Bae Kwon Jeong; Jong Hoon Lee
Journal:  Int J Colorectal Dis       Date:  2016-07-28       Impact factor: 2.571

8.  High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.

Authors:  Ji Soo Park; Hong Jae Chon; Hei-Cheul Jeung; Sang Joon Shin; Sun Young Rha; Joong Bae Ahn; Kang Young Lee; Nam Kyu Kim; Hyun Cheol Chung
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-22       Impact factor: 4.553

9.  Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer.

Authors:  In Ja Park; Hee Cheol Kim; Chang Sik Yu; Jang Hak Yoo; Jin Cheon Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

10.  Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels.

Authors:  Jeong Yeon Kim; Nam Kyu Kim; Seung Kook Sohn; Yong Wan Kim; Kim Jin Soo Kim; Hyuk Hur; Byung Soh Min; Chang Hwan Cho
Journal:  Ann Surg Oncol       Date:  2009-08-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.